CUSIP: G11217117
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / CLASS A ORD SHS
-
Total 13F shares
-
20,088,733
-
Share change
-
+1,207,425
-
Total reported value
-
$201,743,000
-
Price per share
-
$10.04
-
Number of holders
-
67
-
Value change
-
+$12,171,699
-
Number of buys
-
22
-
Number of sells
-
16
Quarterly Holders Quick Answers
What is CUSIP G11217117?
CUSIP G11217117 identifies BIOS - BIOPLUS ACQUISITION CORP - CLASS A ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP G11217117:
Institutional Holders of BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) as of Q3 2022
As of 30 Sep 2022,
BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,088,733 shares.
The largest 10 holders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, Saba Capital Management, L.P., MILLENNIUM MANAGEMENT LLC, Polar Asset Management Partners Inc., Linden Advisors LP, CANTOR FITZGERALD, L. P., D. E. Shaw & Co., Inc., AQR Arbitrage LLC, Starboard Value LP, and Cubist Systematic Strategies, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.